Cargando…

Inactivation of the transforming growth factor β type II receptor in human small cell lung cancer cell lines

Transforming growth factor β (TGF-β) exerts a growth inhibitory effect on many cell types through binding to two types of receptors, the type I and II receptors. Resistance to TGF-β due to lack of type II receptor (RII) has been described in some cancer types including small cell lung cancer (SCLC)....

Descripción completa

Detalles Bibliográficos
Autores principales:	Hougaard, S, Nørgaard, P, Abrahamsen, N, Moses, H L, Spang-Thomsen, M, Skovgaard Poulsen, H
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1999
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362261/ https://www.ncbi.nlm.nih.gov/pubmed/10098728 http://dx.doi.org/10.1038/sj.bjc.6690161

Ejemplares similares

Growth suppression by transforming growth factor beta 1 of human small-cell lung cancer cell lines is associated with expression of the type II receptor.
por: Nørgaard, P., et al.
Publicado: (1994)

Expression and autoregulation of transforming growth factor beta receptor mRNA in small-cell lung cancer cell lines.
por: Nørgaard, P., et al.
Publicado: (1996)

Expression of transforming growth factor beta (TGF beta) receptors and expression of TGF beta 1, TGF beta 2 and TGF beta 3 in human small cell lung cancer cell lines.
por: Damstrup, L., et al.
Publicado: (1993)

In vitro invasion of small-cell lung cancer cell lines correlates with expression of epidermal growth factor receptor.
por: Damstrup, L., et al.
Publicado: (1998)

Profile of differentially expressed genes mediated by the type III epidermal growth factor receptor mutation expressed in a small-cell lung cancer cell line
por: Pedersen, M W, et al.
Publicado: (2001)

Ribozyme-mediated inactivation of mutant K-ras oncogene in a colon cancer cell line
por: Tokunaga, T, et al.
Publicado: (2000)

Expression of cadherin and NCAM in human small cell lung cancer cell lines and xenografts.
por: Rygaard, K., et al.
Publicado: (1992)

Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines
por: Moorsel, C J A van, et al.
Publicado: (1999)

Combined paclitaxel and gemcitabine as first-line treatment in metastatic non-small cell lung cancer: a multicentre phase II study
por: Douillard, J Y, et al.
Publicado: (2001)

Lycobetaine acts as a selective topoisomerase IIβ poison and inhibits the growth of human tumour cells
por: Barthelmes, H U, et al.
Publicado: (2001)

Sequence dependent effect of paclitaxel on gemcitabine metabolism in relation to cell cycle and cytotoxicity in non-small-cell lung cancer cell lines
por: Kroep, J R, et al.
Publicado: (2000)

A dominant negative mutation of transforming growth factor- β receptor type II gene in microsatellite stable oesophageal carcinoma
por: Tanaka, Shinji, et al.
Publicado: (2000)

Phase II study of gemcitabine and vindesine in patients with previously untreated non-resectable non-small-cell lung cancer
por: Sørensen, J B, et al.
Publicado: (1999)

Inactivation of Human Tumor Cell Pro‐urokinase by Granulocyte Elastase
por: Kanayama, Naohiro, et al.
Publicado: (1990)

High brain serotonin levels in migraine between attacks: A 5-HT(4) receptor binding PET study
por: Deen, Marie, et al.
Publicado: (2018)

Phase II study of S-1, a novel oral fluorouracil, in advanced non-small-cell lung cancer
por: Kawahara, M, et al.
Publicado: (2001)

Tumour necrosis factor- α and transforming growth factor- β are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL -2-mediated neovascularization
por: Boldrini, L, et al.
Publicado: (2000)

Expression of the proto-oncogenes c-met and c-kit and their ligands, hepatocyte growth factor/scatter factor and stem cell factor, in SCLC cell lines and xenografts.
por: Rygaard, K., et al.
Publicado: (1993)

Microsatellite instability, Epstein–Barr virus, mutation of type II transforming growth factor β receptor and BAX in gastric carcinomas in Hong Kong Chinese
por: Leung, S Y, et al.
Publicado: (1999)

Does reductive metabolism predict response to tirapazamine (SR 4233) in human non-small-cell lung cancer cell lines?
por: Chinje, E C, et al.
Publicado: (1999)

DNA topoisomerase IIα and -β expression in human ovarian cancer
por: Withoff, S, et al.
Publicado: (1999)

Single-agent gemcitabine in pretreated patients with non-small-cell lung cancer: results of an Argentinean multicentre phase II trial
por: Kooten, M Van, et al.
Publicado: (1999)

αII-spectrin and βII-spectrin do not affect TGFβ1-induced myofibroblast differentiation
por: Piersma, Bram, et al.
Publicado: (2018)

Lack of Bcl10 mutations in testicular germ cell tumours and derived cell lines
por: Schothorst, E M van, et al.
Publicado: (1999)

Human oesophageal adenocarcinoma cell lines JROECL 47 and JROECL 50 are admixtures of the human colon carcinoma cell line HCT 116
por: Wijnhoven, B P L, et al.
Publicado: (2000)

CDKN2A gene inactivation in epithelial sporadic ovarian cancer
por: Niederacher, D, et al.
Publicado: (1999)

Oestrogen inactivation in the colon: analysis of the expression and regulation of 17 β -hydroxysteroidehydrogenase isozymes in normal colon and colonic cancer
por: English, M A, et al.
Publicado: (2000)

Detection of large molecular weight cytokeratin 8 as carrier protein of CA19–9 in non-small-cell lung cancer cell lines
por: Fujita, J, et al.
Publicado: (1999)

Fractionated administration of irinotecan and cisplatin for treatment of non-small-cell lung cancer: a phase II study of Okayama Lung Cancer Study Group
por: Ueoka, H, et al.
Publicado: (2001)

Inhibition of transforming growth factor α (TGF-α)-mediated growth effects in ovarian cancer cell lines by a tyrosine kinase inhibitor ZM 252868
por: Simpson, B J B, et al.
Publicado: (1999)

Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3
por: Baker, A H, et al.
Publicado: (1999)

Activity of high-dose epirubicin combined with gemcitabine in advanced non-small-cell lung cancer: a multicenter phase I and II study
por: van Putten, J W G, et al.
Publicado: (2000)

Characterization and modulation of drug resistance of human paediatric rhabdomyosarcoma cell lines
por: Cocker, H A, et al.
Publicado: (2000)

Study of transforming growth factor alpha for the maintenance of human embryonic stem cells
por: Chen, Andy C. H., et al.
Publicado: (2012)

Expression of hMLH1 is inactivated in the gastric adenomas with enhanced microsatellite instability
por: Baek, M J, et al.
Publicado: (2001)

The influence of 17β-estradiol on annexin 1 expression in the anterior pituitary of the female rat and in a folliculo-stellate cell line
por: Davies, Evelyn, et al.
Publicado: (2007)

Low-dose retinoic acid enhances in vitro invasiveness of human oral squamous-cell-carcinoma cell lines
por: Uchida, D, et al.
Publicado: (2001)

Amphiregulin acts as an autocrine growth factor in two human polarizing colon cancer lines that exhibit domain selective EGF receptor mitogenesis
por: Damstrup, L, et al.
Publicado: (1999)

Reconstitution of Retrograde Transport from the Golgi to the ER In Vitro
por: Spang, Anne, et al.
Publicado: (1998)

Prognostically orientated multimodality treatment including surgery for selected patients of small-cell lung cancer patients stages IB to IIIB: long-term results of a phase II trial
por: Eberhardt, W, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_duk126h1l8jmcu1jhp4f5869dh